… demographic, clinical and histological characteristics of patients with lupus nephritis (LN)
in Western Australia (WA) with regards to their predictive value for patient and renal outcome. …

… In conclusion, lupus nephritis is an uncommon cause of ESKD in Australia and New
Zealand, which is independently associated with higher mortality on dialysis but also a higher …

… patients than in their Caucasian counterparts. The presence and severity of lupus nephritis
is a … the prevalence and severity of lupus nephritis (LN) in patients attending a tertiary referral …

… A higher incidence of hospitalisation secondary to infections was observed in Indigenous
Australian patients in our study. This is in spite of the routine use of trimethoprim-…

… A study of 59 racially undifferentiated patients with LN from an Australian metropolitan area
… , while a large study involving 190 Caucasian patients with LN reported a prevalence of …

… of Lupus Nephritis (LN) in Western Australia was … patients with lupus nephritis (LN),
non-LN-SLE patients, and controls. OR-1 indicates the odds ratio for LN versus non-LN SLE patients, …

… Clinical characteristics and main outcomes for patients with biopsy-proven lupus
nephritis in the Northern Territory by ethnic background. Numbers indicate median values or …

… of photosensitivity and higher incidence of nephritis seen in Indigenous Australian patients
from Far North Queensland. SLE in Indigenous Australian patients were also associated with …

… mortality among those with lupus nephritis,9 as well as Aboriginal Australians treated in
either metropolitan (n=6) or regional centres, including the Northern Territory of Australia (n=22; …

… Of the 27 patients with biopsy proven lupus nephritis, 70% had Class III or IV disease. Average
length of prednisolone use from diagnosis was 32.5 months. Hydroxychloroquine (n = 36) …